DEA hosts industry association conference as part of continued collaboration on prescription drug abuse
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • DEA hosts industry association conference as part of continued collaboration on prescription drug abuse

DEA hosts industry association conference as part of continued collaboration on prescription drug abuse

Junio 25, 2019
|
Share Article
|
Download Press Release
For Immediate Release
Contact: DEA Public Affairs
Phone Number: (571) 776-2508

WASHINGTON - DEA Assistant Administrator, Diversion Control Division John Martin recently hosted a collaborative conference in Washington, D.C. with industry leaders representing the prescription drug supply chain in America.  The purpose of their dialogue was to discuss ways to minimize pharmaceutical diversion while maintaining legitimate commerce and patient access. 

“DEA and those in the drug supply chain must consistently work on collaborative measures in our ongoing efforts to combat prescription drug misuse and find solutions to our nation’s opioid epidemic,” Assistant Administrator Martin said. “We view DEA registrants as partners in this effort, whether it’s pharmaceutical manufacturers, distributors, wholesalers, pharmacies, doctors, or nurse practitioners. DEA’s role is always finding the right balance between providing patients with important medication, while lowering drug diversion, addiction, crime, and overdoses which we have become all too familiar with. We all share a role in the fight against prescription drug misuse and trafficking and we must continue these efforts together. The more we can communicate with our registrant partners, the better.”

As part of this conference, DEA presented attendees with information on federal laws and regulations affecting their industry, and provided a forum to ask questions and share their perspectives about regulatory requirements on current issues. Over the past several years, DEA has redoubled its efforts to better communicate with its registrant population nationwide.  These efforts include regular Practitioner Diversion Awareness Conferences around the country, DEA 360 events, semi-annual National Prescription Drug Take-Back days, and other outreach efforts spearheaded by individual DEA field divisions.

More than 70,000 Americans lost their lives to drug overdose last year, and many of them were opioid-related—heroin, fentanyl, fentanyl analogues, and potent prescription medications such as Oxycodone.

 

###

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

@DEAHQ
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster